Cytarabine (Ara-C) Clinical Trials

4 actively recruiting trials across 2 locations

Also known as: Cytosar-U, Tarabine PFS, cytosine arabinoside (ara-C)

Pipeline

Early 1: 1Phase 2: 2Phase 3: 1

Top Sponsors

Kura Oncology, Inc.1
Joanna Yi1
First Affiliated Hospital of Zhejiang University1
Beijing 302 Hospital1

Indications

Cancer4
Acute Myeloid Leukemia2
Acute T Lymphpblastic Leukemia/Lymphoma1
Pediatric AML1
Acute Myeloid Leukemia (AML)1

Other2 trials

VHAG in Treating R/R T-ALL/LBL

Phase 2

Venetoclax-containing Therapy Combined With Microtransplant for Newly Diagnosed AML

Phase 2

Gilbert, Arizona1 trial

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Banner MD Anderson Cancer Center

Phase 3

Houston, Texas1 trial

UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML

Texas Children's Cancer and Hematology Center

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.